Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis

Background and Objectives: Treatment for elderly (aged ≥75 years) patients with rheumatoid arthritis (RA) is important because they usually have several complications and organ dysfunction and are more susceptible to drug-related adverse events. Abatacept (ABT) treatment is relatively safe in elderl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Shuzo, Matsumoto, Haruki, Temmoku, Jumpei, Fujita, Yuya, Matsuoka, Naoki, Yashiro-Furuya, Makiko, Asano, Tomoyuki, Suzuki, Eiji, Watanabe, Hiroshi, Kanno, Takashi, Migita, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469009/
https://www.ncbi.nlm.nih.gov/pubmed/34577837
http://dx.doi.org/10.3390/medicina57090914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469009/
https://www.ncbi.nlm.nih.gov/pubmed/34577837
http://dx.doi.org/10.3390/medicina57090914

Ejemplares similares